SkylineDx focuses on research and development of molecular diagnostics for oncology and inflammatory diseases.
Investors 1
| Date | Name | Website |
| - | Utrecht Ho... | utrechthol... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 10.01.2022 | BIOCARTIS : MEETS 2021 KEY OBJECTIVES | PRESS RELEASE REGULATED INFORMATION 10 January 2022, 07:00 CET BIOCARTIS MEETS 2021 KEY OBJECTIVES M... | marketscre... |
| 22.04.2021 | BIOCARTIS GROUP NV BIOCARTIS : Q1 2021 BUSINESS UPDATE | PRESS RELEASE REGULATED INFORMATION 22 April 2021, 07:01 CEST BIOCARTIS Q1 2021 BUSINESS UPDATE 70% ... | marketscre... |